Publication | Closed Access

Predictive Performance of the ‘Minto’ Remifentanil Pharmacokinetic Parameter Set in Morbidly Obese Patients Ensuing from a New Method for Calculating Lean Body Mass

ObesityMetabolic SyndromeMorbidly Obese PatientsBody CompositionPharmacokinetic ModelingHealth SciencesMedicineObesity ManagementPharmacotherapyPredictive PerformancePharmacologyPhysiologically-based Pharmacokinetic ModelingPharmacokineticsMetabolic HealthPharmacodynamic ModelingLean Body Mass